Nieuwe PET/CT-scanner: patiënten sneller en dichter bij huis bediend

Op 11 juli 2017 is op campus Sint-Jan de nieuwe PET/CT-scanner in gebruik genomen. Een wereldprimeur, want het gaat om een PET/CT-scanner van de nieuwste generatie die als eerste in zijn soort geïnstalleerd werd. Deze waardevolle aanwinst in de diagnostische beeldvormingsmogelijkheden op de dienst Nucleaire Geneeskunde brengt dit onderzoek voor heel wat patiënten dichter bij huis.

Blijft schildklierkanker een zeldzame ziekte?

De incidentie van schildkliercarcinoom neemt toe. Er is een significante stijging van kleinere tumoren, gedreven door een ontwikkeling van de beeldvorming en de steeds hogere precisie daarvan. In een hechte samenwerking met externe artsen wil het multidisciplinair schildklierkankerzorgteam aangepaste expertise en richtlijngestuurde zorg bieden.

‘The Radium Water Worked Fine until His Jaw Came Off’… of hoe gif nuttig kan zijn voor botgemetastaseerd prostaatcarcinoom

Sinds de ontdekking van het eerste radiumisotoop aan het einde van de 19de eeuw legde de kennis over dit chemische element en over diens negatieve zowel als positieve eigenschappen een hele weg af. Recente studieresultaten brachten … Lees meer

Zevalin-therapie

Non-Hodgkin lymfoom, waarvan de incidentie wereldwijd toeneemt, is een frequente diagnose, met een incidentie van ongeveer 10 gevallen per 100.000 mannen en 8 gevallen per 100.000 vrouwen. Onder de noemer non-Hodgkin lymfoom worden een groot aantal aandoeningen gegroepeerd met een sterk uiteenlopend klinisch gedrag. De globale groep wordt dan ook vaak opgedeeld in laaggradige lymfomen, die traag maar gestadig evolueren en hooggradige lymfomen, die veeleer agressief evolueren.

‘PSMA: de vlag en de lading’.

Brugge
27/10/2016

Minimal count level required for quantification of left ventricular function with gated myocardial perfusion tomography.

2002

Comparison of 180-degree and 360-degree data acquisition in gated myocardial perfusion and in gated blood pool tomography.

2002

Non-invasive measurement of left ventricular function in rats using pinhole gated myocardial perfusion tomography.

2003/05/23-35

Reproducibility of left ventricular function measurements in rat using pinhole gated blood pool tomography.

2003/05/23-35

Dose of 18FDG required for whole body PET using an LSO-PET camera.

2003

Lung scintigraphy for the detection of pulmonary embolism: Evolution and current status in Belgium.

2003

Apport de la tomoscintigraphie osseuse du thorax dans le bilan pré-thérapeutique (TEP-FDG inclus) des tumeurs pulmonaires.

2003

Left ventricular function measured by QGS algorithm from 18FDG gated PET heart studies.

2003

Potential pitfall due to IV-administration of FDG via a port-a-cath.

2004

Comparison of 2- and 3-dimensional clinical FDG-PET studies.

2004

FDG PET predicts prognosis of patients with resectable metastatic colorectal cancer (CRC) treated with preoperative chemotherapy.

2007/06

68Ga-DOTATOC PET/CT in recurrent medullary thyroid carcinoma.

2007/06/4-6

Safety and efficacy of radioimmunotherapy with 90Y-rituximab in patients with relapsed or refractory CD 20+ B cell non Hodgkin’s lymphoma: a pilot study.

2008

Immuno-PET/CT imaging with 89Zr-Rituximab as a prelude for radioimmunotherapy with 90Y-Rituximab in patients with relapsed CD20+ B-Cell non-Hodgkin’s lymphoma.

2008

Role of FDG-PET/CT in Hodgkin’s lymphomas: clinical assessment in a single center.

2009/01/30

Zirconium-89 quantification with PET-CT Discovery LS.

2009/05/15-17

Diagnostic accuracy of 89Zr-rituximab-PET/CT imaging in patients with relapsed CD20+ B-Cell non-Hodgkin’s lymphoma: comparison with 18FDG-PET/CT.

2009/05/15-17

SPECT-CT and the Sentinel Lymph Nodes in Breast cancer patients: additional diagnostic value of CT analysis.

2009

The role of FDG PET(CT) for diagnosis of peritoneal carcinomatosis of colorectal origin.

2099/09/20-24

Comparison of two 68Gallium-labeled octreotide analogues for molecular PET(CT) imaging of neuroendocrine tumours.

2010/05/26-29

Bone marrow activity on 89Zr-rituximab immunoPET/CT predicts hematological toxicity in lymphoma patients treated with 90Y-rituximab.

2012/10/4-5

Contribution of the end-diastolic images in gated perfusion SPECT for the diagnosis of coronary artery disease in women.

1999

180- or 360-degree data acquisition for gated perfusion and blood pool SPECT.

2002/09

Pinhole gated myocardial SPECT in rats: in-vivo measurement of pharmacologically induced cardiodepressive and cardiostimulating effects.

2003

Measurement of the cardio-depressive effects of volatile halogenated anesthetics in rats using pinhole gated myocardial perfusion SPECT.

2003

Reproducibility of left ventricular function measurements in rat using pinhole gated blood pool tomography.

2003

Retrospective evaluation of the clinical value of planar bone scan and SPECT in primary staging (FDG-PET included) of pulmonary tumours.

2003/12

Current and future strategies for optimising patient management through use of PET CT: PET CT in the management of lymphoma.

2007/07/05

Can we predict the ablation of thyroid tissues after 131-iodine treatment for differentiated thyroid carcinomas (DTC)?

2007

Clinical applications of SPECT/CT: from imagine to imaging.

2009/11

Diagnostic accuracy of 89Zr-rituximab-PET/CT imaging in patients with relapsed CD20+ B-cell non-Hodgkin’s lymphoma: comparison with 18FDG-PET/CT.

2009

Immuno-PET imaging with 89Zr-rituximab in patients with CD20+ B-cell lymphoma.

2010/04

Apport de l’immuno-PET/CT dans les lymphomes CD20+.

2010/10/14-16

Immuno-imaging in lymphoma.

2011/09/26-27

New therapeutical use of nuclear medicine : RIT.

2011/10/20-21

3D-dosimetry with 89Zr-immuno-PET/CT as a prelude to radio-immunotherapy: towards patient tailored image-guided therapy?

2012/06/14

The role of molecular imaging in early drug development.

2012

Toon meer

Bone scan findings in calcific tendinitis at the gluteus maximus insertion: some illustrative cases.

Radiol Case Rep; accepted for publication
01/01/2016

Aspecific uptake of 68Ga-PSMA in Paget disease of the bone.

Clin Nucl Med 2016;41:877-878.
01/01/2016

Incidental finding of silent appendicitis on 18F-FDG PET/CT in a patient with lung adenocarcinoma.

Hell J Nucl Med 2016;19:164-166.
01/01/2016

18F-FDG PET imaging in granulomatosis with polyangiitis.

Hell J Nucl Med 2016;19:5-6.
01/01/2016

18F-FDG PET imaging of granulomatosis with polyangiitis – Wegener’s Syndrome.

Hell J Nucl Med 2016;19:53-56.
01/01/2016

When beauty hides a beast.

JBR-BTR 2014;97:192-193.
01/01/2014

Camelid reporter gene imaging: a generic method for in vivo cell tracking.

EJNMMI Res 2014;4:32.
01/01/2014

Positron Emission Tomography in Head and Neck Cancer.

Head and Neck Cancer Imaging, 2006; 17: 329-344, R. Hermans (Ed.), Springer.
2006

Thyroid cancer: 18F-fluoro-2-deoxy-D-glucose Positron Emission Tomography.

Cancer Imaging (Volume 2), 2007; 3.55:699-706, M.A. Hayat (Ed.), Elsevier Academic Press. ISBN978-3-540-22027-5
2007

Sternal foramen simulating osteolytic lesion on scintigraphy and SPET Imaging.

Ann Nucl Med Sci. 2002; 15:227-230
2002

Hypertrophic osteitis of the clavicle.

Clin Nucl Med. 2003; 28(12): 990-1.
2003

Optimal dose of 18F-FDG required for whole-body PET using an LSO PET camera.

Eur J Nucl Med Mol Imaging. 2003; 30(12): 1615-9.
2003

FDG-accumulation in inguinal herniation mimicking metastatic disease.

Clin Nucl Med. 2004; 29(10): 652-3
2004

18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: recent developments in head and neck cancer.

Curr Opin Oncol. 2005; 17(3):249-53.
2005

18FDG PET in oncology: the best and the worst (Review).

Int J Oncol. 2006; 28(5):1249-61.
2006

Thyroid cancers.

Rev Med Brux. 2009 Sep;30(4):279-86.
2009/09

Imaging of tumour-induced osteomalacia using a gallium-68 labelled somatostatin analogue.

BMJ Case Reports 2010; doi:10.1136/bcr.02.2010.2750
2010

The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer.

Radiother Oncol. 2010 Aug;96(2):145-52.
2010/08

Non Hodgkin’s lymphomas: a major breakthrough with immunotherapy.

Rev Med Brux. 2011 Mar-Apr;32(2):83-92
2011/03 - 2011/04

Radioembolization of the Spleen: A Revisited Approach for the Treatment of Malignant Lymphomatous Splenomegaly.

Cardiovasc Intervent Radiol. 2012 Sep 25.
2012/09/25

Port-site metastasis after explorative laparoscopy for an incidental appendiceal mucinous cystadenocarcinoma detected with FDG PET/CT.

JBR-BTR. 2013 Jan-Feb;96(1):43.
01/01-02/2013

Nuclear imaging in relapsing polychondritis.

J Clin Rheumatol 2013;19:55-56.
01/01/2013

Improved quantification in pinhole gated myocardial perfusion SPECT using micro-CT and ultrasound information.

Contrast Media Mol Imaging 2012;7:167-174.
01/01/2012

Cortisone associated diverticular perforation.

JBR-BTR 2011;9:348-349.
01/01/2011

Unilateral breast uptake of 99mTc-pertechnetate.

Hell J Nucl Med 2011;14:76-77.
01/01/2011

Multimodality imaging of cardiac involvement in neurofibromatosis.

J Am Coll Cardiol 2011;57:e209.
01/01/2011

18F-FDG PET/CT imaging of an anti-CTLA-4 antibody-associated autoimmune pancolitis.

Eur J Nucl Med Mol Imaging 2011;38:1390-1391.
01/01/2011

Rapid hepatic clearance of 99mTc-TMEOP: a new candidate for myocardial perfusion imaging.

Contrast Media Mol Imaging 2011;6:178-188.
01/01/2011

Utility of pelvic bone SPET in imaging urinary bladder filling defects in urinary bladder carcinoma, compared with axial CT findings.

Hell J Nucl Med 2010;13:59-62.
01/01/2010

Regional quantitative analysis of small animal myocardial sympathetic innervation and initial application in streptozotocin induced diabetes.

Contrast Media Mol Imaging 2009;4:174-182.
01/01/2009

Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum.

Clin Chem 2009;55:1434-1433.
01/01/2009

Toon meer